WT1 and AL amyloidosis: Chung et al. [73] conducted a phase 1 vaccine trial using autologous Langerhans-type dendritic cells (LCs) electroporated with CT7, MAGE-A3, and Wilms tumor 1 (WT1) mRNA in multiple myeloma patients after autologous stem cell transplantation.